Fleur S Peters

13PUBLICATIONS
54CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Innate immunityHaematological tumoursLiquid biopsiesMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Aug 24, 2026
T-cell immunosenescence limits CD19 CAR T-cell function in chronic lymphocytic leukemia.

|Apr 11, 2025
NK cell-derived IFNγ mobilizes free fatty acids from adipose tissue to promote early B cell activation during viral infection.

Mia Krapić, Inga Kavazović, Sanja Mikašinović

|Mar 03, 2025
Cholesterol homeostasis and lipid raft dynamics at the basis of tumor-induced immune dysfunction in chronic lymphocytic leukemia.

Chaja F Jacobs, Fleur S Peters, Elena Camerini

|Feb 12, 2025
Mitigating T-cell mitochondrial dysfunction in CLL to augment CAR T-cell therapy: evaluation in an immunocompetent model.

Wael Gamal, Nienke B Goedhart, Helga Simon-Molas

|Jul 23, 2024
T-cell dysfunction in CLL is mediated through expression of Siglec-10 ligands CD24 and CD52 on CLL cells.

Jaco A C van Bruggen, Fleur S Peters, Morris Mes

|Aug 08, 2023
T-cell dysfunction by pseudohypoxia and autocrine purinergic signaling in chronic lymphocytic leukemia.

Chiara Montironi, Chaja F Jacobs, Gaspard Cretenet

Pageof 3

Frequent Collaborators

9 joint publications

Arnon P Kater

5 joint publications

Eric Eldering

4 joint publications

Helga Simon-Molas

3 joint publications

Aldo Jongejan